Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.
Status:
Terminated
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out the effectiveness of the experimental
combination of Docetaxel, Cisplatin, and radiation therapy administered prior to the surgical
removal of your esophageal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute